✦ LIBER ✦

Comparing trials for the treatment of myelomatosis

✍ Scribed by Janet A. Dunn; Ian MacLennan

Book ID: 113297669
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 88 KB
Volume: 13
Category: Article
ISSN: 0197-2456
DOI: 10.1016/0197-2456(92)90198-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EVOLVING STRATEGIES FOR THE TREATMENT OF

EVOLVING STRATEGIES FOR THE TREATMENT OF MYELOMATOSIS

✍ J. A. Child 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 777 KB

Results of the mrc myelomatosis trials f

Results of the mrc myelomatosis trials for patients entered since 1980

✍ I. C. M. MacLennan; Krys Kelly; R. A. Crockson; E. H. Cooper; J. Cuzick; Catheri 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 753 KB

## C weekly ABCM or M7 courses are repeated until the patient reaches plateau or relapses. However, if neutropenia < 1.8 x lo9/ or thrombocytopenia <80 x lo9/] persists for more than 6 weeks after a course the patient converts to C weekly. No more than 12 cycles of ABCM are given to any one patien

Alkeran® (Melphalan) in the Treatment of

Alkeran® (Melphalan) in the Treatment of Myelomatosis

✍ Drivsholm, Aa. ;Videbaek, Aa. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 372 KB

TREATMENT OF OSTEOLYTIC MYELOMATOSIS WIT

TREATMENT OF OSTEOLYTIC MYELOMATOSIS WITH MITHRAMYCIN

✍ Stamp, T.C.B.; Child, J.A.; Walker, P.G. 📂 Article 📅 1975 🏛 The Lancet 🌐 English ⚖ 580 KB

Combined chemotherapy versus melphalan a

Combined chemotherapy versus melphalan and prednisolone for treatment of myelomatosis

✍ Gregory, WalterM.; Richards, MichaelA.; Malpas, JamesS. 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 352 KB

Combined chemotherapy with ABCM versus m

Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis

✍ MacLennan, I.C.M.; Chapman, C.; Dunn, J.; Kelly, K. 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 816 KB